JOHN D. RATLIFF

Former Executive Vice President, Chief Executive Officer of Covance Drug Development

CEO

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2019	Labcorp Holdings Inc. (LH)	Former Executive Vice President, Chief Executive Officer of Covance Drug Development	$582,631	$749,996	$3,199,516	—	—	$37,326	$4,569,469
2018	Labcorp Holdings Inc. (LH)	Former Executive Vice President, Chief Executive Officer of Covance Drug Development	$679,750	$758,689	$5,103,644	—	$762,593	$184,961	$7,489,637
2017	Labcorp Holdings Inc. (LH)	Former Executive Vice President, Chief Executive Officer of Covance Drug Development	$659,750	$697,573	$2,978,743	—	$648,415	$13,035	$4,997,516

No earnings-call appearances recorded yet.